Paper Details

  1. Home
  2. Paper Details

The association of alvimopan treatment with postoperative outcomes after abdominal surgery: A systematic review across different surgical procedures and contexts of perioperative care.

Author: AlhashemiMohsen, Amar-ZifkinAlexandre, BaldiniGabriele, BlouinMathieu C, El-KefraouiCharbel, FeldmanLiane S, FioreJulio F, HamadRaphael, LandryTara, LeeLawrence

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Alvimopan is a Food and Drug Administration-approved treatment for accelerating gastrointestinal recovery after abdominal surgery. This study reviews the evidence regarding alvimopan's effects on postoperative outcomes after abdominal surgery.
Paper Details　
Original Abstract of the Article :
Alvimopan is a Food and Drug Administration-approved treatment to accelerate gastrointestinal recovery after abdominal surgery; however, benefits may vary across different procedures and contexts of care. The purpose of this study is to summarize the evidence regarding the effect of alvimopan on pos...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.surg.2020.11.025

データ提供：米国国立医学図書館（NLM）

Alvimopan: Accelerating Gastrointestinal Recovery After Abdominal Surgery

The postoperative gastrointestinal recovery process is an important area of research in surgical care. This systematic review explores the impact of alvimopan, a Food and Drug Administration-approved medication, on postoperative outcomes after abdominal surgery. The review aims to assess the benefits of alvimopan across different surgical procedures and contexts of care.

Alvimopan and Postoperative Outcomes

This study summarizes the existing evidence regarding the effects of alvimopan on postoperative outcomes. Although alvimopan has been approved to accelerate gastrointestinal recovery after abdominal surgery, the review suggests that the benefits may vary depending on the specific surgical procedure and context of care. This highlights the need for further research to refine our understanding of the optimal use of alvimopan in different surgical settings.

Improving Postoperative Care

This research emphasizes the importance of considering the context of care when evaluating the effectiveness of medications like alvimopan. This understanding can help improve the management of postoperative gastrointestinal recovery by tailoring treatment strategies based on the individual patient's needs and the specific surgical procedure they have undergone. This knowledge will be instrumental in ensuring that patients experience optimal recovery after surgery.

Dr.Camel's Conclusion

Imagine a camel caravan traversing the desert, with each camel carrying a valuable load, just as each patient carries a unique set of needs and challenges after surgery. Alvimopan, like a skilled caravan leader, can help guide these patients toward faster recovery. However, just as the journey through the desert requires adaptability and careful planning, the use of alvimopan should be tailored to the specific needs of each patient. Further research will continue to shed light on the optimal use of alvimopan, allowing us to navigate the vast desert of postoperative care with greater precision and care.

Date :
  1. Date Completed 2021-04-30
  2. Date Revised 2021-04-30
Further Info :

Pubmed ID

33380353

DOI: Digital Object Identifier

10.1016/j.surg.2020.11.025

Related Literature

Article Analysis
・Effects of alvimopan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.